Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04909463 · ClinicalTrials.gov registry record · NA
Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma
A NA study, sponsored by CommonSpirit Health.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04909463 is a NA study that was terminated before completion, run by CommonSpirit Health. The registered enrollment target is 8 participants.
The verdict
NCT04909463, a NA study, was terminated before completion, sponsored by CommonSpirit Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to use the Duracore splinting device to measure lung capacities of patients with rib fractures in control and experimental groups to determine if lung capacities improve with the splint.
Interventions
- DEVICE Chest Splint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-12-04 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04909463
The ClinicalTrials.gov registry entry for NCT04909463 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CommonSpirit Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chest Splint is the first listed.
NCT04909463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04909463 about?
NCT04909463 is a clinical study titled "Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma". The purpose of this study is to use the Duracore splinting device to measure lung capacities of patients with rib fractures in control and experimental groups to determine if lung capacities improve with the splint.
What is the current status of trial NCT04909463?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2020-12-04. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT04909463?
The interventions under investigation include: Chest Splint (DEVICE).
Who is sponsoring clinical trial NCT04909463?
This trial is sponsored by CommonSpirit Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.